Otsuka Chemical Co Ltd Discontinued
FDA Approved Drugs

Otsuka Chemical Co Ltd Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 20
  • Latest Approval Date Nov 13, 2017
  • Data Source FDA
  • First Approval Date Oct 14, 1997
All
41
View
Discontinued
20
View
RX
21
View
Company Overview

Company

Otsuka Chemical Co Ltd Discontinued

Country

Japan

Website

Visit Website

Email

yuichiro-shibata@otsukac.co.jp

Social Profiles

Company Snapshot

Otsuka Chemical Co Ltd Discontinued

3-2-27, Ote-Dori, Chuo-Ku, Osaka, 540-0021

Japan

www.otsukac.co.jp:443/ yuichiro-shibata@otsukac.co.jp View on Map
FDA Approved Drug Records ( 20 records )
2004
10 Dec
Discontinued Application: 21713

Drug Name

ABILIFY

Product Number

1

Dosage Form

-

Strength

1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2004-12-10

21713 / 1

Active Ingredient

ARIPIPRAZOLE

Application Number

21713

Product Number

1

Dosage Form

-

Strength

1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2004-12-10

Regulatory Status

Discontinued

2006
07 Jun
Discontinued Application: 21729

Drug Name

ABILIFY

Product Number

2

Dosage Form

-

Strength

10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-06-07

21729 / 2

Active Ingredient

ARIPIPRAZOLE

Application Number

21729

Product Number

2

Dosage Form

-

Strength

10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-06-07

Regulatory Status

Discontinued

2006
07 Jun
Discontinued Application: 21729

Drug Name

ABILIFY

Product Number

3

Dosage Form

-

Strength

15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-06-07

21729 / 3

Active Ingredient

ARIPIPRAZOLE

Application Number

21729

Product Number

3

Dosage Form

-

Strength

15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-06-07

Regulatory Status

Discontinued

2006
07 Jun
Discontinued Application: 21729

Drug Name

ABILIFY

Product Number

4

Dosage Form

-

Strength

20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-06-07

21729 / 4

Active Ingredient

ARIPIPRAZOLE

Application Number

21729

Product Number

4

Dosage Form

-

Strength

20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-06-07

Regulatory Status

Discontinued

2006
07 Jun
Discontinued Application: 21729

Drug Name

ABILIFY

Product Number

5

Dosage Form

-

Strength

30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-06-07

21729 / 5

Active Ingredient

ARIPIPRAZOLE

Application Number

21729

Product Number

5

Dosage Form

-

Strength

30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-06-07

Regulatory Status

Discontinued

2006
20 Sep
Discontinued Application: 21866

Drug Name

ABILIFY

Product Number

1

Dosage Form

-

Strength

9.75MG/1.3ML (7.5MG/ML)

Approval Date

2006-09-20

21866 / 1

Active Ingredient

ARIPIPRAZOLE

Application Number

21866

Product Number

1

Dosage Form

-

Strength

9.75MG/1.3ML (7.5MG/ML)

Approval Date

2006-09-20

Regulatory Status

Discontinued

2017
13 Nov
Discontinued Application: 207202

Drug Name

ABILIFY MYCITE KIT

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

2017-11-13

207202 / 1

Active Ingredient

ARIPIPRAZOLE

Application Number

207202

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

2017-11-13

Regulatory Status

Discontinued

2017
13 Nov
Discontinued Application: 207202

Drug Name

ABILIFY MYCITE KIT

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2017-11-13

207202 / 2

Active Ingredient

ARIPIPRAZOLE

Application Number

207202

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2017-11-13

Regulatory Status

Discontinued

2017
13 Nov
Discontinued Application: 207202

Drug Name

ABILIFY MYCITE KIT

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2017-11-13

207202 / 3

Active Ingredient

ARIPIPRAZOLE

Application Number

207202

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2017-11-13

Regulatory Status

Discontinued

2017
13 Nov
Discontinued Application: 207202

Drug Name

ABILIFY MYCITE KIT

Product Number

4

Dosage Form

-

Strength

15MG

Approval Date

2017-11-13

207202 / 4

Active Ingredient

ARIPIPRAZOLE

Application Number

207202

Product Number

4

Dosage Form

-

Strength

15MG

Approval Date

2017-11-13

Regulatory Status

Discontinued

2017
13 Nov
Discontinued Application: 207202

Drug Name

ABILIFY MYCITE KIT

Product Number

5

Dosage Form

-

Strength

20MG

Approval Date

2017-11-13

207202 / 5

Active Ingredient

ARIPIPRAZOLE

Application Number

207202

Product Number

5

Dosage Form

-

Strength

20MG

Approval Date

2017-11-13

Regulatory Status

Discontinued

2017
13 Nov
Discontinued Application: 207202

Drug Name

ABILIFY MYCITE KIT

Product Number

6

Dosage Form

-

Strength

30MG

Approval Date

2017-11-13

207202 / 6

Active Ingredient

ARIPIPRAZOLE

Application Number

207202

Product Number

6

Dosage Form

-

Strength

30MG

Approval Date

2017-11-13

Regulatory Status

Discontinued

2006
02 May
Discontinued Application: 21790

Drug Name

DACOGEN

Product Number

1

Dosage Form

-

Strength

50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-05-02

21790 / 1

Active Ingredient

DECITABINE

Application Number

21790

Product Number

1

Dosage Form

-

Strength

50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-05-02

Regulatory Status

Discontinued

1997
14 Oct
Discontinued Application: 20292

Drug Name

FERRISELTZ

Product Number

1

Dosage Form

-

Strength

600MG/PACKET

Approval Date

1997-10-14

20292 / 1

Active Ingredient

FERRIC AMMONIUM CITRATE

Application Number

20292

Product Number

1

Dosage Form

-

Strength

600MG/PACKET

Approval Date

1997-10-14

Regulatory Status

Discontinued

1999
15 Jan
Discontinued Application: 20863

Drug Name

PLETAL

Product Number

1

Dosage Form

-

Strength

50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1999-01-15

20863 / 1

Active Ingredient

CILOSTAZOL

Application Number

20863

Product Number

1

Dosage Form

-

Strength

50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1999-01-15

Regulatory Status

Discontinued

1999
15 Jan
Discontinued Application: 20863

Drug Name

PLETAL

Product Number

2

Dosage Form

-

Strength

100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1999-01-15

20863 / 2

Active Ingredient

CILOSTAZOL

Application Number

20863

Product Number

2

Dosage Form

-

Strength

100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1999-01-15

Regulatory Status

Discontinued

1997
06 Nov
Discontinued Application: 20695

Drug Name

RAXAR

Product Number

1

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

1997-11-06

20695 / 1

Active Ingredient

GREPAFLOXACIN HYDROCHLORIDE

Application Number

20695

Product Number

1

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

1997-11-06

Regulatory Status

Discontinued

1998
14 May
Discontinued Application: 20695

Drug Name

RAXAR

Product Number

2

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

1998-05-14

20695 / 2

Active Ingredient

GREPAFLOXACIN HYDROCHLORIDE

Application Number

20695

Product Number

2

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

1998-05-14

Regulatory Status

Discontinued

1998
14 May
Discontinued Application: 20695

Drug Name

RAXAR

Product Number

3

Dosage Form

-

Strength

EQ 600MG BASE

Approval Date

1998-05-14

20695 / 3

Active Ingredient

GREPAFLOXACIN HYDROCHLORIDE

Application Number

20695

Product Number

3

Dosage Form

-

Strength

EQ 600MG BASE

Approval Date

1998-05-14

Regulatory Status

Discontinued

2009
19 May
Discontinued Application: 22275

Drug Name

SAMSCA

Product Number

3

Dosage Form

-

Strength

60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2009-05-19

22275 / 3

Active Ingredient

TOLVAPTAN

Application Number

22275

Product Number

3

Dosage Form

-

Strength

60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2009-05-19

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    41 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
20 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ABILIFY

Application Number

21713

Product Number

1

Active Ingredient

ARIPIPRAZOLE

Dosage Form

-

Strength

1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit